NASDAQ:BRKRBruker Stock Price, Forecast & News

$43.44

+0.22 (+0.51 %)

(As of 06/3/2020 04:00 PM ET)

Add

Compare

Today's Range

$42.42

Now: $43.44▼

$43.74

50-Day Range

$35.02

MA: $39.21▼

$44.18

52-Week Range

$30.78

Now: $43.44▼

$54.49

Volume436,700 shs

Average Volume862,936 shs

Market Capitalization$6.70 billion

P/E Ratio38.44

Dividend Yield0.37%

Beta1.38

Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, defect-detection equipment for semiconductor process control, and spark optical emission spectroscopy systems, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments. In addition, it offers superconducting and non-superconducting materials and devices. The company serves pharmaceutical, biotechnology, and diagnostics companies; chemical, food and beverage, clinical, and polymer companies; nonprofit laboratories; contract research organizations, academic institutions, medical schools, nonprofit or for-profit forensics, environmental and clinical microbiology laboratories, and hospitals and government departments and agencies, as well as agriculture, and food and beverage safety companies; nanotechnology, semiconductor, and industrial companies; and raw material manufacturers and other businesses through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Beat the Market (BTM) Rank^™

2.2 Analyst's Opinion

Consensus Rating
Bruker has received a consensus rating of Hold. The company's average rating score is 2.38, and is based on 6 buy ratings, 6 hold ratings, and 1 sell rating.
Price Target Upside/Downside
According to analysts' consensus price target of $45.42, Bruker has a potential upside of 4.6% from its current price of $43.44.
Amount of Analyst Coverage
Bruker has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

2.4 Community Rank

Outperform Votes
Bruker has received 621 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Bruker has received 676 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Bruker has received 52.12% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Bruker and other stocks. Vote “Outperform” if you believe BRKR will outperform the S&P 500 over the long term. Vote “Underperform” if you believe BRKR will underperform the S&P 500 over the long term. You may vote once every thirty days.

3.3 Dividend Strength

Dividend Leadership
Bruker is a leading dividend payer. It pays a dividend yield of 0.37%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
Bruker does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Bruker is 10.19 %. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Bruker will have a dividend payout ratio of 9.64 % next year. This indicates that Bruker will be able to sustain or increase its dividend.

1.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Bruker insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 26.50% of the stock of Bruker is held by insiders.
Percentage Held by Institutions
69.97% of the stock of Bruker is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5 Earnings and Valuation

Earnings Growth
Earnings for Bruker are expected to grow by 44.35% in the coming year, from $1.15 to $1.66 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Bruker is 38.44, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 16.10.
Price to Earnings Ratio vs. Sector
The P/E ratio of Bruker is 38.44, which means that it is trading at a less expensive P/E ratio than the Computer and Technology sector average P/E ratio of about 41.58.
Price to Earnings Growth Ratio
Bruker has a PEG Ratio of 3.15. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Bruker has a P/B Ratio of 7.29. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

2.29 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Analytical instruments

Sub-IndustryLife Sciences Tools & Services

SectorComputer and Technology

Current SymbolNASDAQ:BRKR

Previous Symbol

CUSIP11679410

CIK1109354

Webwww.bruker.com

Phone978-663-3660

Debt

Debt-to-Equity Ratio1.04

Current Ratio2.60

Quick Ratio1.78

Price-To-Earnings

Trailing P/E Ratio38.44

Forward P/E Ratio37.77

P/E Growth3.15

Sales & Book Value

Annual Sales$2.07 billion

Price / Sales3.23

Cash Flow$2.10 per share

Price / Cash Flow20.71

Book Value$5.96 per share

Price / Book7.29

Profitability

EPS (Most Recent Fiscal Year)$1.57

Net Income$197.20 million

Net Margins8.69%

Return on Equity25.09%

Return on Assets8.58%

Miscellaneous

Employees7,230

Outstanding Shares154,230,000

Market Cap$6.70 billion

Next Earnings Date8/6/2020 (Estimated)

OptionableOptionable

Receive BRKR News and Ratings via Email

Sign-up to receive the latest news and ratings for BRKR and its competitors with MarketBeat's FREE daily newsletter.

Bruker (NASDAQ:BRKR) Frequently Asked Questions

How has Bruker's stock been impacted by COVID-19 (Coronavirus)?

Bruker's stock was trading at $40.00 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, BRKR shares have increased by 8.6% and is now trading at $43.44. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Bruker?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last year. There are currently 1 sell rating, 6 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Bruker.

When is Bruker's next earnings date?

Bruker is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Bruker.

How were Bruker's earnings last quarter?

Bruker Co. (NASDAQ:BRKR) announced its earnings results on Friday, March, 27th. The medical research company reported $0.53 EPS for the quarter, missing the consensus estimate of $0.58 by $0.05. The medical research company earned $599.90 million during the quarter, compared to analyst estimates of $585.83 million. Bruker had a net margin of 8.69% and a return on equity of 25.09%. View Bruker's earnings history.

How often does Bruker pay dividends? What is the dividend yield for Bruker?

Bruker announced a quarterly dividend on Wednesday, May 13th. Investors of record on Monday, June 1st will be given a dividend of $0.04 per share on Friday, June 19th. This represents a $0.16 annualized dividend and a dividend yield of 0.37%. The ex-dividend date of this dividend is Friday, May 29th. View Bruker's dividend history.

What price target have analysts set for BRKR?

13 equities research analysts have issued 1 year price objectives for Bruker's stock. Their forecasts range from $27.00 to $63.00. On average, they expect Bruker's share price to reach $45.42 in the next year. This suggests a possible upside of 4.6% from the stock's current price. View analysts' price targets for Bruker.

Has Bruker been receiving favorable news coverage?

News headlines about BRKR stock have been trending somewhat positive this week, according to InfoTrie. InfoTrie identifies negative and positive media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Bruker earned a media sentiment score of 0.9 on InfoTrie's scale. They also gave media coverage about the medical research company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news aboutBruker.

Are investors shorting Bruker?

Bruker saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 3,420,000 shares, a decline of 8.6% from the April 30th total of 3,740,000 shares. Based on an average daily trading volume, of 973,000 shares, the short-interest ratio is presently 3.5 days. Currently, 3.3% of the company's stock are short sold. View Bruker's Current Options Chain.

Who are some of Bruker's key competitors?

Some companies that are related to Bruker include Thermo Fisher Scientific (TMO), Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO), Waters (WAT), PerkinElmer (PKI), BIO-TECHNE (TECH), Charles River Laboratories Intl. (CRL), Luminex (LMNX), Pacific Biosciences of California (PACB), Fluidigm (FLDM), Harvard Bioscience (HBIO), aTyr Pharma (LIFE) and BG Medicine (BGMD). View all competitors.

What other stocks do shareholders of Bruker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bruker investors own include Walt Disney (DIS), Cisco Systems (CSCO), CVS Health (CVS), Alibaba Group (BABA), AbbVie (ABBV), Intel (INTC), Bank of America (BAC), Bristol-Myers Squibb (BMY), Micron Technology (MU) and AT&T (T).

Who are Bruker's key executives?

Bruker's management team includes the following people:

Dr. Frank H. Laukien, Chairman, CEO & Pres (Age 59)
Mr. Gerald N. Herman, CFO, VP & Corp. Controller (Age 61)
Dr. Mark R. Munch, Exec. VP and Pres of Bruker Nano Group & Bruker Nano Surfaces Division (Age 57)
Mr. Juergen Srega, Pres of Bruker CALID Group & Bruker Daltonics Division (Age 64)
Dr. Falko Busse, Exec. Officer (Age 52)

What is Bruker's stock symbol?

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

Who are Bruker's major shareholders?

Bruker's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (3.28%), Janus Henderson Group PLC (1.83%), Acadian Asset Management LLC (1.61%), Invesco Ltd. (1.61%), GWM Advisors LLC (1.13%) and Alliancebernstein L.P. (1.10%). Company insiders that own Bruker stock include Burkhard Prause, Frank H Laukien, Marc A Kastner and Mark Munch. View institutional ownership trends for Bruker.

Which institutional investors are selling Bruker stock?

BRKR stock was sold by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, APG Asset Management N.V., APG Asset Management N.V., APG Asset Management N.V., AJO LP, Acadian Asset Management LLC, BlackRock Inc., and Geode Capital Management LLC. Company insiders that have sold Bruker company stock in the last year include Burkhard Prause, Frank H Laukien, Marc A Kastner, and Mark Munch. View insider buying and selling activity for Bruker.

Which institutional investors are buying Bruker stock?

BRKR stock was acquired by a variety of institutional investors in the last quarter, including Invesco Ltd., Vaughan Nelson Investment Management L.P., Fuller & Thaler Asset Management Inc., Ceredex Value Advisors LLC, First Trust Advisors LP, Morgan Stanley, Morgan Stanley, and Pembroke Management LTD. View insider buying and selling activity for Bruker.

How do I buy shares of Bruker?

Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Bruker's stock price today?

One share of BRKR stock can currently be purchased for approximately $43.44.

How big of a company is Bruker?

Bruker has a market capitalization of $6.70 billion and generates $2.07 billion in revenue each year. The medical research company earns $197.20 million in net income (profit) each year or $1.57 on an earnings per share basis. Bruker employs 7,230 workers across the globe.

What is Bruker's official website?

The official website for Bruker is www.bruker.com.

How can I contact Bruker?

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at 978-663-3660 or via email at [email protected]

This page was last updated on 6/3/2020 by MarketBeat.com Staff